The Science

A Technical Presentation of the  Vapor Cartridge Technology

This section explains the Vapor Cartridge Technology in enough detail to show how it will change the entire cannabis industry. Whereas this section explains the core technology, the intellectual properties afforded by the patents extend well beyond this seminal technology. Prospective licensee(s) should review the patents disclosed in the Patent Portfolio section which will validate this industry changing technology.

The Vapor Cartridge Technology consists of three system components:

#1: Thermal Distillation Process (US 9,220,294 et al.)​

  • This process utilizes the physical properties of the acidic cannabinoids contained within the botanical cannabis. The acidic cannabinoids can be decarboxylated and vaporized at a much lower temperature than the temperature at which the toxins in the plant material volatize resulting in a toxin free, hot vapor that is rich in neutralized cannabinoids. This is a ‘whole plant’ extraction in that it extracts all of the 150 plus cannabinoids, all terpenes as well as trace flavonoids, carotenoids and chlorophylls. Thus, the specific varietal of botanical cannabis controls the formulation.

  • Referring to figure 1, the pure hot cannabinoid vapors et al., contained within the thermal distillation chamber, condense onto a chilled conductive substrate, coating it densely with cannabinoids et al. This process can be well controlled.

  • The coating weight (measured in gm/cm2) and its formulation (i.e., percentage of each cannabinoid) are a function of easily measured and controlled process parameters.

  • The thermal distillation process produces a sheet of conductive substrate with a precise, highly concentrated, coating of cannabinoids.

Figure 1

#2. The method for converting the coated sheet substrate into a Vapor Cartridge (US 9,408,986 et al.)

  • The Vapor Cartridge is constructed from an extruded aluminum substrate. Liquid aluminum is extruded to create a conductive substrate which consists of multiple parallel electrical circuits defined by parallel, low-resistance, conductors on either side of high-resistance heating elements (please refer to figure 2 to understand the basic concept of volatilizing the coating on the substrate). When a current is driven through one of the parallel conductors through the high resistance heating element section returning to the other parallel conductor, that element heats up and volatilizes the coating of cannabinoids previously deposited.
Figure 2
  • Referring to figure 3, the process to converting the flat extruded aluminum substrate, coated with its high concentration of cannabinoids, and into a Vapor Cartridge is to simply roll it up into a spiral with the multiple parallel conductors outwardly exposed. Non-conductive spacers create an open airflow tunnel through the Vapor Cartridge.
Figure 3
Figure 4
  • The volatilizing chamber of the Drug Delivery Device performs the critical function of extracting the cannabinoids. Figure 4 shows a functional block diagram depicting how the exposed parallel conductors of the Vapor Cartridge match up to the contacts in the volatizing chamber. When directed by the patient, a well-controlled current is driven through the selected section, volatizing its coating of cannabinoids.
Figure 5
  • Referring to figure 5, the ability of the Vapor Cartridge form factor to meet all local, state, and federal packaging, labeling, and tracking requirements is of enormous value. This would enable the Vapor Cartridge to get approved for distribution through both the vast pharmaceutical channels and the distribution channels for adult beverages!
  • The Thermal Distillation Process is also a very environmentally friendly process.
    • No chemicals are used
    • The spent organic material can be put back into the soil
    • The aluminum Vapor Cartridge is recyclable
    • The Vapor Cartridges themselves have a long storage life, allowing processors to use finished product inventory to balance changing seasonal supply with changing demand.

#3: The Drug Delivery Device (US 9,380,813 et al.)

  • Figure 6 depicts the basic concept of extracting the cannabinoids, from the Vapor Cartridge by driving a current through two exposed parallel low-resistance conductors of a given section, heating that section, and vaporizing the drugs therein. A significant advantage of this design is that the cannabinoid-rich vapors can be mixed with other beneficial vapors, for example:

    • Water vapor would moisturize the air passage

    • A taste vapor (e.g., menthol) would make the process more pleasant

    • A bronchial dilator would improve the drugs’ transfer into the bloodstream.

Figure 6
Figure 7
  • Figure 7 depicts a physical Drug Delivery Device designed to implement the concepts conceptually described in figure 6. (A detailed technical explanation will be given to prospective licensee(s))
  • Figure 8 graphically depicts the essence of this fantastic technology. The function of the technology, shown in the top view, is to extract the cannabinoids et al. from raw botanical cannabis and deliver the drugs safely and accurately to the patient’s lungs. The process for doing that is shown in the bottom view and each step in this process has been detailed in the previous pages.

Figure 8

Once successfully commercialized the Vapor Cartridge Technology will be a game changing, paradigm shifting, disruptive technology!

  • It will be, far and away, the most cost-efficient manner to deliver cannabinoid vapors as measured by $/mg/ml of cannabinoids in the bloodstream. Even when heavily taxed, the process will still produce a very profitable product because it will be in high demand (Exceeding customers’ expectations) and still be the least expensive recreational product at the retail level, well below black market ‘street price’. From a customer’s perspective, it’s “A better high at a lower price”.
  • It will be the only technology that can provide the dose control, formulation control, and purity assurance of inhaled botanical vapors required of an FDA-approved drug.
  • This is the rapid-onset, non-smoked cannabinoid delivery system that the Institute of Medicine (IOM) has long been requesting.
  • It defines a Drug Delivery Device that will meet ISO 11.040.01 and thus can be approved by the FDA for the delivery of ingestible cannabinoid vapors. This will quickly become the medical and recreational standard for ingesting cannabinoid drugs in vapor form.
  • It defines a Vapor Cartridge manufacturing process that is highly efficient, high capacity, and high quality (meeting ISO 9001:2000). Furthermore, the process was designed with controllable inputs and measurable outputs enabling state-of-the-art statistical process control and six-sigma discipline to drive continuous improvement for years to come (such as yield, capacity, throughput, unit cost, and overall quality). Furthermore, the commercialization process will lead to additional intellectual properties in terms of patents, trade secrets, and trademarks.
  • The Vapor Cartridge construction enables it to meet all the logistical and regulatory requirements of the TTB, ATF, and state-regulated distribution channels for alcoholic beverages for adult recreational use. Thus, providing profits for all in the supply chain (farmers, processors, distributors, and retailers). Furthermore, this supply chain has the enormous benefit of being able to use the existing physical and communication infrastructure which can easily and efficiently regulate and collect taxes. Furthermore, retail sales through wine and liquor stores provide both convenience for the customer and the assurance of no sales to minors.

  • It will significantly increase the value of legal cannabis crops as source material for vapor cartridge processing while substantially devaluing, even eliminating, the retail demand for raw botanical cannabis (a.k.a. dried flower heads) as a means for extracting and ingesting cannabinoid vapors. Note: Not all raw cannabis is illegal, but all illegal cannabis is raw.